Literature DB >> 25700304

Obesity and Fatty Pancreatic Infiltration Are Risk Factors for Pancreatic Precancerous Lesions (PanIN).

Vinciane Rebours1, Sébastien Gaujoux2, Gaspard d'Assignies3, Alain Sauvanet4, Philippe Ruszniewski5, Philippe Lévy6, Valérie Paradis7, Pierre Bedossa7, Anne Couvelard8.   

Abstract

PURPOSE: The roles of intravisceral and subcutaneous fat are unknown, and the prevalence of precancerous lesions in obese patients was never evaluated. This study aims to assess the frequency and severity of pancreatic intraepithelial neoplasia (PanIN) and to correlate pathologic findings with metabolic abnormalities, type of fat, and fatty pancreatic infiltration. EXPERIMENTAL
DESIGN: Normal pancreatic tissue from surgical specimens was analyzed. Fatty infiltration and fibrosis in intra- and extralobular locations and PanIN lesions were assessed. General characteristics were collected: body mass index (BMI), diabetes, and tobacco intake. Liver steatosis and subcutaneous and intravisceral fat were assessed by CT scan (ImageJ software).
RESULTS: Of note, 110 patients were included [median age, 53.8 (17-85) years]. Arterial hypertension, diabetes, and tobacco intake were found in 19%, 9%, and 23%, respectively. Median BMI was 24 (16-37; BMI < 25: 45%, 25 ≤ 30: 24%, ≥30: 11%). Overall, PanIN lesions were found in 65% (type I, II, and III PanIN in 62%, 38%, and 1%, respectively). Fibrosis and fatty pancreas (intra- and extralobular locations) were found in 1% and 24% and in 30% and 51%, respectively. A correlation was observed between PanIN lesions and fatty pancreas [extralobular (0.01) and intralobular (<0.0001)], intralobular fibrosis (0.003), high BMI (P = 0.02), and subcutaneous (P = 0.02) and intravisceral fat (P = 0.02). The number of PanIN lesions was correlated with intravisceral fat (r = 0.22, P = 0.04), but not with subcutaneous fat (r = 0.14, P = 0.22). In multivariate analysis, PanIN lesions were associated with intralobular fibrosis [OR, 5.61; 95% confidence interval (CI), 1.18-42.99] and intralobular fat (OR, 17.86; 95% CI, 4.935-88.12).
CONCLUSIONS: Obesity (especially android obesity) and pancreatic fatty infiltration are risk factors for pancreatic precancerous lesions. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2015        PMID: 25700304     DOI: 10.1158/1078-0432.CCR-14-2385

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  58 in total

1.  A Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreas.

Authors:  Olca Basturk; Seung-Mo Hong; Laura D Wood; N Volkan Adsay; Jorge Albores-Saavedra; Andrew V Biankin; Lodewijk A A Brosens; Noriyoshi Fukushima; Michael Goggins; Ralph H Hruban; Yo Kato; David S Klimstra; Günter Klöppel; Alyssa Krasinskas; Daniel S Longnecker; Hanno Matthaei; G Johan A Offerhaus; Michio Shimizu; Kyoichi Takaori; Benoit Terris; Shinichi Yachida; Irene Esposito; Toru Furukawa
Journal:  Am J Surg Pathol       Date:  2015-12       Impact factor: 6.394

2.  Association between hyperechogenic pancreas and pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasms.

Authors:  Koichiro Mandai; Koji Uno; Kojiro Nakase; Takuji Kawamura; Kenjiro Yasuda
Journal:  J Med Ultrason (2001)       Date:  2019-05-08       Impact factor: 1.314

Review 3.  Metabolic Interactions in the Tumor Microenvironment.

Authors:  Costas A Lyssiotis; Alec C Kimmelman
Journal:  Trends Cell Biol       Date:  2017-07-19       Impact factor: 20.808

4.  Pancreatic Head Resection Following Roux-en-Y Gastric Bypass: Operative Considerations and Outcomes.

Authors:  M T Trudeau; L Maggino; B L Ecker; C M Vollmer
Journal:  J Gastrointest Surg       Date:  2019-09-04       Impact factor: 3.452

5.  The Burden of Systemic Adiposity on Pancreatic Disease: Acute Pancreatitis, Non-Alcoholic Fatty Pancreas Disease, and Pancreatic Cancer.

Authors:  Ahmad Malli; Feng Li; Darwin L Conwell; Zobeida Cruz-Monserrate; Hisham Hussan; Somashekar G Krishna
Journal:  JOP       Date:  2017

6.  Independent association between prediabetes and future pancreatic fat accumulation: a 5-year Japanese cohort study.

Authors:  Hajime Yamazaki; Shinichi Tauchi; Miho Kimachi; Mitsuru Dohke; Nagisa Hanawa; Yoshihisa Kodama; Akio Katanuma; Yosuke Yamamoto; Shunichi Fukuhara; Shingo Fukuma
Journal:  J Gastroenterol       Date:  2017-12-13       Impact factor: 7.527

7.  Low-fat Dietary Pattern and Pancreatic Cancer Risk in the Women's Health Initiative Dietary Modification Randomized Controlled Trial.

Authors:  Li Jiao; Liang Chen; Donna L White; Lesley Tinker; Rowan T Chlebowski; Linda V Van Horn; Peter Richardson; Dorothy Lane; Haleh Sangi-Haghpeykar; Hashem B El-Serag
Journal:  J Natl Cancer Inst       Date:  2018-01-01       Impact factor: 13.506

8.  Pancreatic duct hyperplasia/dysplasia in type 1 diabetes and pancreatic weight in individuals with and without diabetes. Reply to Kobayashi T, Aida K, Fukui T et al [letter] and Saisho Y [letter].

Authors:  Martha L Campbell-Thompson; Desmond A Schatz; John S Kaddis; Mark A Atkinson
Journal:  Diabetologia       Date:  2016-02-09       Impact factor: 10.122

9.  CT radiomics to predict high-risk intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Jayasree Chakraborty; Abhishek Midya; Lior Gazit; Marc Attiyeh; Liana Langdon-Embry; Peter J Allen; Richard K G Do; Amber L Simpson
Journal:  Med Phys       Date:  2018-09-27       Impact factor: 4.071

Review 10.  Peroxisome proliferator activated receptors at the crossroad of obesity, diabetes, and pancreatic cancer.

Authors:  Simone Polvani; Mirko Tarocchi; Sara Tempesti; Lapo Bencini; Andrea Galli
Journal:  World J Gastroenterol       Date:  2016-02-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.